Observational Study
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Aug 15, 2020; 11(8): 358-369
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.358
Access to insulin delivery devices and glycated haemoglobin in lower-income countries
Emma Louise Klatman, Graham David Ogle
Emma Louise Klatman, Graham David Ogle, Life for a Child Program, Glebe, NSW 2037, Australia
Author contributions: Ogle GD conceived the study; Klatman EL and Ogle GD designed the questionnaire; Klatman EL administered the questionnaire and analysed the results; Klatman EL and Ogle GD wrote the manuscript.
Supported by the Leona M and Harry B Helmsley Charitable Trust, No. 2019PG-T1D023.
Institutional review board statement: This is not applicable for our manuscript.
Informed consent statement: This is not applicable for our manuscript.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Emma Louise Klatman, BSc, MSc, Academic Research, Life for a Child Program, Diabetes NSW and ACT, 26 Arundel Street, Glebe, NSW 2037, Australia. emma@lifeforachild.org
Received: February 3, 2020
Peer-review started: February 3, 2020
First decision: March 5, 2020
Revised: June 3, 2020
Accepted: July 1, 2020
Article in press: July 1, 2020
Published online: August 15, 2020
Core Tip

Core tip: This study reviews access to insulin delivery devices and glycated haemoglobin testing supplies in 37 less-resourced countries. Although these two essential non-insulin supplies are required to effectively manage Type 1 diabetes, the study’s results demonstrate that their access is largely insufficient within the health systems of the countries surveyed. Specific access barriers are summarised and recommendations to overcome these are advocated for by the authors.